Cytea Bio: We are thrilled to announce the publication of our latest scientific article in Cells MDPI!

We are thrilled to announce the publication of our latest scientific article in Cells MDPI!
Mechanically Active Gut-on-Chip Model is finally out on Nature Biomedical Engineering

Mechanically Active Gut-on-Chip Model is finally out on Nature Biomedical Engineering
Croda opens advanced lipids manufacturing facility in Pennsylvania

Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, today announces the opening of a pioneering new lipids manufacturing facility in Lamar, Pennsylvania, USA.
Atlantic Bone Screen – new member

Atlantic Bone Screen is a French CRO providing non-GLP preclinical services.
ALPX – new member

ALPX, an EMBL spin-off and French CRO, delivers fully transparent structural biology services to biotech and pharma companies.
Exiris – new international member

Exiris is a preclinical stage company that uses a unique combination of technology platforms to discover novel oncology targets and to generate innovative therapeutic agents for the treatment of oncology indications with high unmet medical need.
J&S Preclinical Solutions – new international member

At J&S Preclinical Solutions, we are dedicated to propelling your preclinical drug development programs to new heights.
RLM Consulting – new international member

RLM Consulting provides a wide range of regulatory affairs supports for the development of disruptive Investigational Medicinal Products (IMP) and Investigational New Drugs (IND), from early nonclinical development to the late phases of clinical development.
Orelis – new member

ORELIS conçoit, fabrique et fournit des unités de filtration membranaire et leurs procédés associés.
Mabqi, the French specialist in therapeutic antibodies for oncology, obtains €5 million in non-dilutive financing from France 2030’s “Innovations in Biotherapies and Bioproduction” call for projects

Mabqi, a biotechnology company specializing in the development of therapeutic antibodies for the treatment of cancer, today announced that it has obtained €5 million in funding from the French government under the Innovations in Biotherapies and Bioproduction call for projects under of the France 2030 program operated on behalf of the French government by Bpifrance.
FluoSphera – new international member

FluoSphera has developed human multi-tissue systems that accurately replicate and analyze how a drug interacts with multiple organs.
Decode Pharma Partners – new member

Decode Pharma Partners fournit 3 axes de prestations de services à ces clients
5QBD-Biotech – new member

5QBD-Biotech – Pioneering Regulatory Science for Innovative Biological Products
Qubicon – new international member

Qubicon reinvents data management, real-time monitoring and process control in biotechnological and pharmaceutical R&D laboratories as well as in entire GMP production facilities.
HawkCell – new member

HawkCell est une société deeptech spécialisé dans l’Imagerie à Résonance Magnétique (IRM) dans la santé animale.
LiveDrop – new member

LiveDrop est une spin-off innovante de l’Université de Liège, fondée en 2022 et dirigée par Stéphanie van Loo.
Charles River Laboratories – new member

Depuis plus de 75 ans, Charles River Laboratories intervient sur l’ensemble du cycle de développement des produits pharmaceutiques.
PlasmidFactory – new international member

PlasmidFactory, the leading CDMO of plasmid/minicircle DNA and the driving force in the development of gene vectors for gene/cell therapy and genetic vaccination.
CellQuest – new member

CellQuest développe des solutions de production de biothérapies
Novaptech – new member

Seule entreprise française sur les 20 biotechs mondiales spécialisées dans le domaine des aptamères, Novaptech, spin-off d’un grand laboratoire académique de l’Université de Bordeaux, cible des secteurs stratégiques et en pleine croissance.
UNVEIL – new member

Issue de l’Institut d’Optique Graduate School, Université Paris-Saclay, UNVEIL est une start-up d’instrumentation visant à faciliter le développement et la production de biomédicaments.
New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark

New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark
Epigene Labs – new member

Epigene Labs is creating intelligence-augmenting solutions for precision oncology research and drug development.
BD – new member

Depuis 125 ans, acteur unique des technologies médicales, BD conçoit, fabrique et commercialise des dispositifs médicaux pour répondre aux enjeux sanitaires d’aujourd’hui et de demain.
AGS Therapeutics Expands Leadership Team, Appointing Dr. Kristin Luther to Drive CMC and Analytics

AGS Therapeutics, a preclinical-stage biotech company pioneering Microalgae Extracellular Vesicles (MEV) as a novel, universal delivery system, announced today the appointment of Dr. Kristin Luther as an Operating Partner for Chemistry, Manufacturing, and Controls (CMC) and Analytics.
Menarini Biotech – new international member

Menarini Biotech is a fast-growing, fully integrated CDMO for biologics located in the greater Rome area, Italy.
CyRISBio – new member

CyRISBio accompagne toutes les entreprises en sciences du vivant sur leurs enjeux d’automatisation des processus de sample management.
Ariana Pharma enters a new era with Dr. Pascale Bouillé taking the helm of the company.

Ariana Pharma enters a new era with Dr. Pascale Bouillé taking the helm of the company.
Integrated DNA Technologies – new member

For more than 35 years, Integrated DNA Technologies has enabled genomics laboratories with an oligonucleotide manufacturing process with the most advanced synthesis, modification, purification, and quality control capabilities available.
Scinus Cell Expansion – new international member

SCINUS provides an innovative, controlled and cost-effective bioreactor solution to automate cell culture processes
MGI TECH – new international member

Having established itself as a leader in clinical high-throughput gene sequencers and automation platforms, MGI is now leveraging its expertise to develop tailored automation solutions designed to meet the unique demands of your workflow.
ESTBB – new member

Créée en 1952, l’ESTBB est portée par une expertise métiers solide et par une dimension internationale marquée.
INDICIA PRODUCTION – new member

INDICIA PRODUCTION est une CMO spécialisée dans la fabrication de solutions liquides, stériles ou non, selon le cahier des charges spécifiques de ses clients.
Medisim analytix – new member

At MediSim, we specialize in pharmacometrics
Osivax Announces First Participant Vaccinated in Phase 2a Clinical Booster Trial of Influenza Vaccine Candidate OVX836

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that the first participant has been vaccinated in a Phase 2a clinical trial (NCT06582277) evaluating OVX836, its broad-spectrum influenza vaccine candidate as a booster in participants previously administered with OVX836.
White Raven – new international member

White Raven is a flexible CDMO who specializes in GMP Formulation and Aseptic Filling of Injectable Drugs for small to medium sized batches.
LYO-X – new international member

LYO-X provides strategic consulting and PK/PD modelling services dedicated to the preclinical and clinical development of biologics and cell based therapies.
Cebiphar – new member

Cebiphar, prestataire de services dans le support analytique au développement pharmaceutique depuis 1979, propose des solutions techniques et règlementaires pour sécuriser la chaine d’approvisionnement de nos clients.
ACM PHARMA – new member

ACM PHARMA (a part of TERANGA Group) is a CRO and reference partner of the bio/pharmaceutical industry for contamination control.
EVEREST Project Aims to Revolutionise Biomedical Research with Extracellular Vesicles in 2025.

EVEREST Project Aims to Revolutionise Biomedical Research with Extracellular Vesicles in 2025.
Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture

Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture
SYNTHEX Consulting – new member

SYNTHEX Consulting est un Cabinet de conseil spécialisé en Gestion de Projet, en Communication interpersonnelle dédiée aux équipes projet ainsi qu’en Gestion de Risques.
BiomimX – new international member

BiomimX is a pioneer in Organ on a Chip (OoC) technology, producing the next generation of clinically relevant in-vitro models for pharmaceutical drug discovery and testing.
Protagene CGT – new international member

ProtaGene is a world-leading CRO partner for the biopharmaceutical and cell and gene therapy industries.
Charmide – new member

Charmide, entreprise individuelle représentée par Elise Jacquier-Lefaivre, est une société de conseil et de formation dans le domaine de la bioéthique.
BioAZ – new member

BioAZ, biotech basée en Nouvelle-Aquitaine créée en 2022, conçoit et développe des immunothérapies pour la santé et le bien-être animal.
Fusion Antibodies – new international member

Fusion Antibodies plc is a early discovery partner located in Belfast, which develop and optimizes therapeutic and diagnostic antibodies.
BioClonal – new international member

Based in Spain, BioClonal specializes in developing monoclonal antibodies tailored to your project’s needs, regardless of how challenging the target may be.
Biocair – new member
Filiale du groupe La Poste, Biocair propose depuis 36 ans des solutions logistiques personnalisées dédiées à l’industrie pharmaceutique.
AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS’ MEV technology as a vaccinal delivery system

AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS’ MEV technology as a vaccinal delivery system
SPIKIMM – new member

Société de biotechnologie développant des anticorps dans le domaine infectieux.
Lauxera Capital Partners – new member

Lauxera Capital Partners est un gérant d’actifs indépendant, international et spécialisé dans le secteur de la santé.
Cegav – new member

Depuis 1990, la Cegav, implantée à proximité de Chartres, est une entreprise familiale.
Biodyssey – new member

Biodyssey is a team of experts at the service of entrepreneurs and project leaders, specialized in the biotechnology sector.
BIOMUNEX Pharmaceuticals – new member

BIOMUNEX Pharmaceuticals is a biopharmaceutical company based in Paris, led by an international team, focused on the discovery and development of disruptive immuno-therapeutics in oncology, thanks to its proprietary next-generation bi- and multi-specific antibody, the BiXAb® platform.
Motac and Cynbiose Announce Strategic Partnership to Accelerate Central Nervous System Research

Motac and Cynbiose Announce Strategic Partnership to Accelerate Central Nervous System Research
ImCheck Receives FDA Fast Track Designation for ICT01 in Combination with Azacitidine and Venetoclax in First-Line Acute Myeloid Leukemia for Patients Unfit for Induction Chemotherapy Treatment

ImCheck Receives FDA Fast Track Designation for ICT01 in Combination with Azacitidine and Venetoclax in First-Line Acute Myeloid Leukemia for Patients Unfit for Induction Chemotherapy Treatment
Announcing Avanti Research – a Croda brand

Announcing Avanti Research – a Croda brand
LAPORTE EURO – new member

LAPORTE EURO, the European subsidiary of LAPORTE&ASSOCIES, a Canadian company with over 450 employees, specializing in engineering for the pharmaceutical, agri-food and bioindustrial industries.
ImCheck Awarded EUR 20.18 Million from the French Government Through the France 2030 Investment and Innovation Plan

ImCheck Awarded EUR 20.18 Million from the French Government Through the France 2030 Investment and Innovation Plan
SPyDiag – new member

SPyDiag is a biotech start-up spun out of research at the Universities of Tours and Amiens.
Axfen Bio – new member

Axfen Bio is a French CRO offering recombinant protein production services (from gene synthesis to purification/quality control).
Optimal Industrial Technologies – new international member

Optimal Industrial Technologies has nearly 4 decades of experience in the automation and optimisation of control and data management systems for the pharmaceutical, biotech and life science industries.
Immerscio.bio – new member

Immerscio.bio is a training platform that meets the skills needs of the strategic biomanufacturing sector supported by France BioLead as part of France 2030.
CSafe – new member

CSafe offers the most complete solution for thermal transport of pharmaceutical products requiring a cold chain on a global scale.
Calvagone – new member

At Calvagone, we specialize in providing top-tier pharmacometrics consulting services, dedicated to supporting our customers throughout their drug development process.
AGS Therapeutics Announces the Appointment of Dr. Renee T. Williams as an Independent Board Member

AGS Therapeutics Announces the Appointment of Dr. Renee T. Williams as an Independent Board Member
B2G Life Sciences – new member

B2G Life Sciences is a science-driven, international, medical consulting company, dedicated to clinical development.
AbTx (Antibody for Therapy) – new member

AbTx (Antibody for Therapy) is an expert in the development of an enzymatic bio-conjugation technology that will enable the design and development of homogeneous, stable, high-quality conjugated antibodies and antibody fragments.
AdaptVac announces a collaboration with GTP Bioways to manufacture its cVLP based placental malaria vaccine

AdaptVac announces a collaboration with GTP Bioways to manufacture its cVLP based placental malaria vaccine
Screening & Fluidics – new member

Screening & Fluidics provides Ultra-High Throughput Screening Services using its GotaHit Fluorescence Activated Droplet Sorting (FADS) platform in a wide range of applications.
CELLforCURE – New member

CELLforCURE is currently one of the very few companies worldwide experienced with manufacturing cell and gene therapy drugs that have been administered to large numbers of patients in real life commercial setting.
PEPperPRINT – new international member

PEPperPRINT is an innovative biotechnology company based in Heidelberg, Germany, and the leading supplier of high-density peptide and protein chips for antibody characterization or fingerprint analysis of antibody responses from biological samples.
Tataa Biocenter – new international member

Pioneering large-scale PCR innovation
Evosciences – new international member

Evosciences is a European company which, since 2003, has specialized in the financing and resale of scientific equipment for companies in the life sciences sector, and more specifically for biotech companies.
StarkAge Therapeutics – new member

Biotech company specializing in the development of targeted therapies against senescent cells in age-related pathologies.
Association Bernard Gregory – new member

The ABG is a network of companies, PhDs and higher education and research establishments, bringing together professionals with common interests in research, development and innovation.
Lonza Bioscience – new member

Lonza, headquartered in Basel, Switzerland, is a laboratory supplier as well as a CDMO.
ImCheck to Present Promising ICT01 Datafrom the EVICTION Study at ASCO 2024

Interim data from Phase I/II EVICTION study shows favorable safety profile and promising efficacy for ICT01 in combination with pembrolizumab in refractory melanoma patients
Blue Bees Therapeutics announces the appointment of Dr Marie-Noëlle Ly asits chief development officer and Thomas-Paul Descamps as board member.

Blue Bees Therapeutics, a biopharmaceutical company specialized in
the development of first-in-class immunotherapy to treat cancer
Persea – new member

Persea is a French biotech developing a game-changing cell and gene therapy for liver cancer.
Sourcin – new international member

Transform procedures into textless multimedia.
Leanbio – new member

Leanbio is a leading Biopharmaceutical CDMO offering end-to-end services in the field of recombinant proteins, mRNA and pDNA.
Nova Biomedical – new member

Nova Biomedical is a world leader in the field of in vitro diagnostics (IVD), distinguished by its international scope and over 40 years of expertise in the development, manufacture and marketing of whole blood analyzers and readers.
GEG Tech – new member

GEG Tech’s mission is to design safe and powerful innovations deriving from genetic engineering.
Blue Bees Therapeutics – new member

Blue Bees Therapeutics is a biotechnology company founded in 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancer, based on a disruptive technology (i.Ther) discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis at CEA Paris-Saclay.
Igyxos Biotherapeutics – new member

Igyxos Biotherapeutics, a French biotechnology company, is dedicated to addressing the growing global need for improved infertility solutions through novel therapeutics that make treatment more effective and efficient for men and women.
Pipebio – new international member

PipeBio is an integrated cloud platform for no-code, end-to-end bioinformatic workflows for therapeutic antibody and biologics discovery.
Takis – new international member

Takis, a biotechnology company based in Rome, Italy, has over 10 years of experience in drug discovery.
Ardena – new international member

Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials.
AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration.

AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT/EP2023/078634 – Publication – WO 2024/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.
Lovaltech announces the closing of a €6.8 million seed financing round for clinical trials of its first nasal vaccine against COVID-19

Lovaltech announces the closing of a €6.8 million seed financing round for clinical trials of its first nasal vaccine against COVID-19
Myonex closes Creapharm acquisition expanding global services

Myonex has completed the previously announced acquisition of
CREAPHARM’s pharmaceutical services business .
Pierre Fabre’s vibegron gains CHMP positive opinion for OAB

The opinion is a significant step for towards marketing authorisation from the European Commission.
ProteoGenix and Cizzle Biotechnology Collaboration Forges New Paths in Early Detection of Lung Cancer through Innovative Antibody Development

ProteoGenix, a leading antibody development contract research organization (CRO), in a landmark collaboration with Cizzle Biotechnology Holdings PLC, an innovative UK-based diagnostics developer, announces the successful development of new antibodies targeting the CIZ1B biomarker, which is closely associated with early-stage lung cancer.
Ariana Pharma announces important AI collaboration in precision oncology for treatment of advanced cancer

Ariana Pharma, a leading Artificial Intelligence drug development company, announced today that it has entered a €3 million consortium
Delta Diagnostics – new international member

Delta Diagnostics is a Dutch biotech company that specializes in creating highly sensitive and selective biosensors using integrated photonics.
SATT Aquitaine Science Transfert – new member

La SATT Aquitaine Science Transfert représente 11 établissements de recherche d’Aquitaine. Sa mission est d’accélérer la transformation des inventions issues de la recherche académique en innovations.
Firalis Molecular Precision Grant Program in partnership with Vizgen

Firalis Molecular Precision Grant Program in partnership with Vizgen
Turing Biosystems – new member

Our software platform integrates any and all types of clinical/biological data, analyses patient therapy responses, and designs better treatments.
Manpower Experts et Cadres – new member

Manpower Experts et Cadres est le partenaire privilégié de ses clients sur le recrutement relatif aux postes de cadres et d’expertises.
CliniSciences – new member

CliniSciences est une société française, présente dans 15 pays européens et aux Etats-Unis, ayant différentes activités :
BGene – new member

Depuis 2014, BGene concentre ses activités de recherche et développement sur la conception de procédés de production innovants et soutenables pour des molécules à forte valeur ajoutée.
Osivax Announces Vaccination of Last Patient in Phase 2a Clinical Trial Evaluating OVX836 Combined with QIVs

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that all participants have completed their final visit in the Phase 2a clinical trial (NCT05734040) evaluating OVX836, Osivax’ broad-spectrum influenza A vaccine candidate, in combination with Quadrivalent Influenza Vaccines (QIVs).
Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

Rapid Novor Inc and MAbSilico announced that they have partnered to provide the world’s first AI-driven HDX-MS epitope mapping service for antibody development.
Toulouse Tech Transfer (TTT) – new member

Toulouse Tech Transfer (TTT) est la Société d’Accélération du Transfert de Technologies (SATT) d’Occitanie ouest, créée en 2012 dans le cadre du Programme des Investissements d’Avenir.
Abcely – new member

La mission de Abcely est de développer de nouvelles technologies médicales et pharmaceutiques innovantes dans le domaine du traitement des cancers des muqueuses, offrant ainsi aux patients en impasse thérapeutique une nouvelle solution basée sur un tout nouveau concept d’immunothérapie en cancérologie.
Real Research – new international member

Real Research fournit des outils et des services de culture cellulaire en 3D (3DCC). Real Research est spécialisée dans la fabrication d’hydrogels pour les cultures cellulaires 3D sous la marque LifeGel®.
Dynamic Biosensors – new international member

Dynamic Biosensors développe, produit et fournit des instruments et des consommables pour l’analyse avancée des interactions biomoléculaires sur des biopuces ou directement sur la cellule individuelle, permettant des percées dans la drug discovery, la recherche en sciences de la vie, les thérapies cellulaires et géniques.
SEED Biosciences – new international member

By accelerating the use of precision medicine in personalised therapies, SEED Biosciences aims to set new standards in single-cell biology to benefit patients.
Atonco – new member

Atonco est une société radiopharmaceutique au stade clinique qui développe des produits radiopharmaceutiques innovants utilisant l’astate-211, un radionucléide émetteur de particules alpha pour le traitement du cancer.
GENXMAP – new member

Fondée en 2020, GENXMAP est une entreprise leader en France dans le domaine de la génomique et de l’analyse transcriptomique.
MYONEX TO ACQUIRE CREAPHARM’S CLINICAL & COMMERCIALPACKAGING AND BIOSERVICES BUSINESS

Myonex, a leading global clinical trial supply company, has reached an agreement with the owners of Creapharm Group to acquire the Creapharm Clinical Packaging & distribution and Commercial Packaging business and bioservices, headquartered in Reims, France with additional locations in Bordeaux and Bailly-Romainvilliers, France, and Marietta, Georgia, USA
ACAVI – New member

ACAVI is a company specializing in Executive Search and Recruitment, Specialized Assessment and Strategic and Operational Consulting dedicated to Top and Middle Management of companies in the Pharmaceutical, Biotechnology and Lab Suppliers sectors.
Refeyn – new international member

Refeyn pioneers mass photometry technology, producing a disruptive new generation of analytical instruments.
StemInov – new member

StemInov is a biopharmaceutical company specializing in the development of “WhartSep”, an innovative mesenchymal stem cell therapy with immunomodulatory properties of particular interest in the treatment of septic shock.
World Courier – new international member

Our full-service logistics and storage solutions help you seamlessly deliver innovation.
Kinnate Biopharma Inc. sells its experimental pan-RAF inhibitor, exarafenib, to Laboratoires Pierre Fabre
Pierre Fabre Médicament, SAS (“Laboratoires Pierre Fabre”), a global player in oncology
Kinnate Biopharma Inc. sells its experimental pan-RAF inhibitor, exarafenib, to Laboratoires Pierre Fabre

Pierre Fabre Médicament, SAS (“Laboratoires Pierre Fabre”), a global player in oncology
MaaT Pharma announces positive DSMB review of ongoing Phase 1 trial evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)

MaaT Pharma announces positive DSMB review of ongoing Phase 1 trial evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)
GIO Therapeutics – nouveau membre international

GIO Therapeutics stands at the forefront of medical innovation, specialising in the development of G protein-coupled receptor (GPCR)-targeted pharmaceuticals.
Osivax Announces Vaccination of First Participant in First-in-Human Trial Evaluating Sarbecovirus Vaccine Candidate OVX033

Osivax Announces Vaccination of First Participant in First-in-Human Trial Evaluating Sarbecovirus Vaccine Candidate OVX033
Firalis Molecular Precision (FMP) – new member

Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced multi-omics solutions and tailored contract research services to the Life Sciences sector.
LivyBio – new member

Consulting firm in cell and gene therapy.
METTLER TOLEDO – new member

Within the METTLER TOLEDO Group, the Industrial Analysis division focuses on analytical measurement solutions for industrial manufacturing processes.
AnalysisMode – new international member

AnalysisMode is at the forefront of bioprocess transformation with SimCell, our state-of-the-art platform that harnesses the power of digital process twins and artificial intelligence.
SCTbio – new international member

SCTbio is a cell therapy and retrovirus vector CDMO spinning off from the SOTIO group in 2021
StromaCare appoints Georges Rawadi as CEO
StromaCare appoints Georges Rawadi as CEO
StromaCare appoints Georges Rawadi as CEO

StromaCare appoints Georges Rawadi as CEO
Synthelis devient Synthelis Biotech

Synthelis est ainsi devenue SYNTHELIS BIOTECH depuis cette date.
Unchained Labs – new member

We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it.
HEPHAISTOS-Pharma secures a €2 million seed round

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq
Oncodesign Services Acquires ZoBio

Oncodesign Services, a Leading European CRO In Preclinical Drug Discovery Acquires ZoBio, A CRO Specialized in Small Molecule Drug Discovery.
Proteintech – new international member

Proteintech is a leading manufacturer of antibodies, immunoassays, proteins and Nanobodies.
AGS Therapeutics Strengthens its Patent portfolio on Microalgae Extracellular Vesicles (MEV) with an International Patent

MEVs are a universal delivery system; suitable for delivering innovative therapeutics, vaccines and gene therapies.